tailieunhanh - THE ROLE OF MUTUAL FUNDS IN THE INVESTMENT PROCESS IN THE CARIBBEAN

Current investment management practice typically assumes that the OE portfolio is defined by the fund manager’s investment “style.” Roughly, style refers to a subset of the investment universe in which a manager is constrained to operate, such as small capitalization stocks versus large stocks, or “value” versus “growth” firms. The style con- straint may be a self-declared specialization, or it may be imposed on the manager by the firm. This leads to the idea of “style expo- sures,” analogous to the risk exposures implied by the multiple-beta asset pricing models. In this approach the OE portfolio has the same style exposures as the portfolio to be evaluated | --- THE ROLE OF MUTUAL FUNDS IN THE INVESTMENT PROCESS IN THE CARIBBEAN Presented by ----- Mr. Clarry Benn Executive Director Trinidad and Tobago Unit Trust Corporation OUTLINE Players in the Regional Mutual Funds Industry Funds under Management Types of Funds on offer to Investors Recipients of mobilized funds of the Mutual Fund Industry Primary Beneficiaries 05-May-2003 The Role of Mutual Funds in the Investment Process in the Caribbean 2 THE REGIONAL MUTUAL FUND .

• Quỹ đầu tư
• Pancreatic Cancer
• Network Centric Understanding
• Systems
• Pancreatic Ductal
• Adenocarcinoma Signalling
• Novel Biomarkers
• BMC Cancer
• Pancreatic carcinoma
• Pancreatic exocrine insufficiency
• Unresectable pancreatic cancer
• Pancreatic enzyme replacement therapy
• Recurrent pancreatic ductal adenocarcinoma
• Recurrent pancreatic cancer
• Metastatic pancreatic cancer
• Gemcitabine nab paclitaxel
• Combination chemotherapy
• Pancreatic ductal adenocarcinoma
• Neoadjuvant chemotherapy
• Perioperative chemotherapy
• Randomized trial
• Pancreatic stellate cells
• Extracellular matrix
• PSC CM induced chemoresistance
• Overall survival
• Pancreatic intraepithelial neoplasia
• Cancer stem cells
• Tumor stroma
• Tumor microenvironment
• Recurrence pattern
• Pancreatic neoplasm
• Pancreatic juice
• Mutation analysis
• Liquid biopsy
• Elderly patient
• Non surgical treatment
• Charlson comorbidity index
• Physical activity
• Life course
• Pancreatic cancer risk
• Life course physical activity
• Differential diagnosis
• Pancreatic head cancer
• Distal cholangiocarcinoma
• Histopathological similarity
• Liver metastases
• Unexpected liver metastasis
• Peritoneal carcinomatosis
• Advanced disease
• Lethal cancers
• Cancer incidence
• Locally advanced pancreatic cancer
• Induction chemotherapy
• Salvage therapy
• Prognostic factor
• Borderline resectable pancreatic cancer
• Neoadjuvant chemoradiotherapy
• Progression of vascular invasion
• Confidence interval
• Cancer stem cell
• Protein kinase C
• Nab paclitaxel
• Lymphoid cell types
• Tumor growth
• Human clinical treatment
• Neoadjuvant therapy
• Anatomically widely spread
• Intensity modulated radiation therapy
• Advanced cancer
• Biliary tract cancer
• Lung cancer
• Multimodal intervention
• Enzyme gamma glutamyltransferase
• Serum gamma glutamyltransferase
• Tumor cell proliferation
• Tumor progression
• Human pancreatic cancer
• Severity assessment
• Animal models
• Murine model of pancreatic cancer
• Non invasive methods compared
• European surgeons
• Hormone sensitive lipase
• Adipose tissue inflammation
• Pancreatic inflammation
• Animal model
• H 1 parvovirus
• Oncolytic virotherapy
• Clinical protocol